Seres Therapeutics
MCRB
#8812
Rank
ยฃ0.11 B
Marketcap
ยฃ12.89
Share price
3.12%
Change (1 day)
-3.87%
Change (1 year)

Revenue for Seres Therapeutics (MCRB)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of ยฃ98.91 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Seres Therapeutics from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A-100%
2023 ยฃ98.91 M1578.8%
2022 ยฃ5.89 M-94.51%
2021 ยฃ0.10 B340.61%
2020 ยฃ24.36 M-7.39%
2019 ยฃ26.31 M18.16%
2018 ยฃ22.26 M-6.24%
2017 ยฃ23.75 M34.65%
2016 ยฃ17.63 M
2015 N/A
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Xencor
XNCR
ยฃ0.12 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
ยฃ84.62 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Agios Pharmaceuticals
AGIO
ยฃ33.61 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA